Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download223 - 228 of 232 results
Assessing the Financial Impact of Translational Pharmaceutics® - Tufts CSDD Report
AAPS 2021: Pharmaceutical and clinical performance comparisons of modified release multiparticulates and matrix tablet formulations
Strategies for Accelerating the Development of Modified Release Oral Forms
A PBPK based simulation study to predict potential gastric transit time and permeability driven drug – drug interactions caused by Rybelsus® (semaglutide + SNAC)
Use of an Exploratory Mechanistic In-Vitro In-Vivo Relationship (IVIVR) to Support Gastro-Retentive Formulation Development
Drug-Drug Interaction Studies (DDI Studies)
Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.